BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 1720490)

  • 1. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
    Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
    Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
    Reisbach G; Bartke I; Kempkes B; Kostka G; Ellwart J; Birner A; Thalmeier K; Mailhammer R; Bornkamm GW; Ullrich A
    Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
    Ashman LK; Bühring HJ; Aylett GW; Broudy VC; Müller C
    J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
    Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
    Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow.
    Bühring HJ; Müller CA; Letarte M; Gougos A; Saalmüller A; van Agthoven AJ; Busch FW
    Leukemia; 1991 Oct; 5(10):841-7. PubMed ID: 1961019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia.
    Bühring HJ; Herbst R; Kostka G; Bossenmaier B; Bartke I; Kropshofer H; Kalbacher H; Busch FW; Müller CA; Schlessinger J
    Cancer Res; 1993 Sep; 53(18):4424-31. PubMed ID: 7689935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells.
    Yamaguchi Y; Gunji Y; Nakamura M; Hayakawa K; Maeda M; Osawa H; Nagayoshi K; Kasahara T; Suda T
    Exp Hematol; 1993 Aug; 21(9):1233-8. PubMed ID: 7687219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow.
    Ashman LK; Cambareri AC; To LB; Levinsky RJ; Juttner CA
    Blood; 1991 Jul; 78(1):30-7. PubMed ID: 1712644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-kit expression by B cell precursors in mouse bone marrow. Stimulation of B cell genesis by in vivo treatment with anti-c-kit antibody.
    Rico-Vargas SA; Weiskopf B; Nishikawa S; Osmond DG
    J Immunol; 1994 Mar; 152(6):2845-52. PubMed ID: 7511630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes.
    deCastro CM; Denning SM; Langdon S; Vandenbark GR; Kurtzberg J; Scearce R; Haynes BF; Kaufman RE
    Exp Hematol; 1994 Sep; 22(10):1025-33. PubMed ID: 7522182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
    Clarke BJ; Liao SK; Leeds C; Soamboonsrup P; Neame PB
    Cancer Res; 1987 Aug; 47(16):4254-9. PubMed ID: 3475169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture.
    Morita S; Tsuchiya S; Fujie H; Itano M; Ohashi Y; Minegishi M; Imaizumi M; Endo M; Takano N; Konno T
    Leukemia; 1996 Jan; 10(1):102-5. PubMed ID: 8558913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia.
    Wang C; Curtis JE; Geissler EN; McCulloch EA; Minden MD
    Leukemia; 1989 Oct; 3(10):699-702. PubMed ID: 2476640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13.
    Nishii K; Kita K; Miwa H; Kawakami K; Nakase K; Masuya M; Morita N; Omay SB; Otsuji N; Fukumoto M
    Leukemia; 1992 Jul; 6(7):662-8. PubMed ID: 1378163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A; Cairoli R; Morra E; Larizza L
    Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
    Sillaber C; Strobl H; Bevec D; Ashman LK; Butterfield JH; Lechner K; Maurer D; Bettelheim P; Valent P
    J Immunol; 1991 Dec; 147(12):4224-8. PubMed ID: 1721642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.